Now you can login using your social network passwords,


Login with your



Please login below will have no access to any personal information or passwords on these accounts.  



Last updateSun, 06 Nov 2016 10am

Back You are here: Home Health Health Health Products Aspirin may prolong life of prostate cancer...

Aspirin may prolong life of prostate cancer...

About 2,200 of the men involved (37%) were receiving anticoagulants (warfarin, clopidogrel, enoxaparin, and/or aspirin). The risk of death from prostate cancer was compared between those taking anticoagulants and those who were not.

The findings demonstrated that deaths over a period of 10 years from prostate cancer were significantly lower in the group taking anticoagulants, compared to those who were not - 3% versus 8%, respectively.

The risks of cancer recurrence and bone metastasis also were significantly lower. Further analysis suggested that this benefit was primarily derived from taking aspirin, as opposed to other types of anticoagulants.

The suggestion that aspirin, a frequently prescribed and relatively well-tolerated drug, may improve outcomes in prostate cancer is of particular interest as prostate cancer is a common non-skin cancer among men.

"The results from this study suggest that aspirin prevents the growth of tumor cells in prostate cancer, especially in high-risk prostate cancer, for which we do not have a very good treatment currently," said Dr. Kevin Choe, assistant professor of radiation oncology at the University of Texas Southwestern, where the research was conducted.

"But we need to better understand the optimal use of aspirin before routinely recommending it to all prostate cancer patients."

The study was published in the Journal of Clinical Oncology.